Package 65162-836-14

{"route": ["TOPICAL"], "spl_id": "71431b46-bc28-4938-95e5-eff50aae1390", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0365162836141"], "unii": ["X4HES1O11F"], "rxcui": ["141859"], "spl_set_id": ["9167ea4a-959d-402c-96b4-619395821c01"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (65162-836-14)  / 5 g in 1 TUBE", "package_ndc": "65162-836-14", "marketing_start_date": "20201111"}], "brand_name": "Acyclovir", "product_id": "65162-836_71431b46-bc28-4938-95e5-eff50aae1390", "dosage_form": "CREAM", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "65162-836", "generic_name": "Acyclovir", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA208766", "marketing_category": "ANDA", "marketing_start_date": "20201111", "listing_expiration_date": "20261231"}